Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Sep. 22, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi C&Y Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Shanxi C&Y Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanxi C&Y Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi C&Y Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi C&Y Pharmaceutical Group Co Ltd (SZSE:300254) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010

Website

http://www.cy-pharm.com

Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.

Executives

Zuo Xue Min	Supervisors
Huang Le Qun	Director
Zhang Zhen Biao	Executives
Yu Jun Xian	Directors, Directors, and Executives
Zhao Qun	Director
Weng Zhan Guo	Director
Geng Chun Feng	Director
Pang Xiao Quan	Supervisors
Zhong Hai Rong	Directors, executives
Xuan Hang	Director

Shanxi C&Y Pharmaceutical Group Co Headlines

No Headlines